Pfizer’s Brandt to retire
Executive Summary
U.S. President of Pharmaceutical Operations Peter Brandt will retire from Pfizer after 28 years with the company; his position has been eliminated under the restructuring of the U.S. pharmaceutical division. Brandt, a prominent member of Pfizer's management in recent years, previously served as senior VP-global pharmaceutical finance prior to organizational changes implemented by CEO Jeffrey Kindler in August (1"The Pink Sheet" Aug. 21, 2006, p. 3)...